| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |